These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17106625)

  • 1. Both host prion protein 131-188 subregion and prion strain characteristics regulate glycoform of PrP Sc.
    Yokoyama T; Shimada K; Masujin K; Iwamaru Y; Imamura M; Ushiki YK; Kimura KM; Itohara S; Shinagawa M
    Arch Virol; 2007; 152(3):603-9. PubMed ID: 17106625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the biological and biochemical characteristics of bovine spongiform encephalopathy prions during interspecies transmission in transgenic mice models.
    Yokoyama T; Masujin K; Iwamaru Y; Imamura M; Mohri S
    J Gen Virol; 2009 Jan; 90(Pt 1):261-8. PubMed ID: 19088297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight prion strains have PrP(Sc) molecules with different conformations.
    Safar J; Wille H; Itri V; Groth D; Serban H; Torchia M; Cohen FE; Prusiner SB
    Nat Med; 1998 Oct; 4(10):1157-65. PubMed ID: 9771749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
    Kuczius T; Koch R; Keyvani K; Karch H; Grassi J; Groschup MH
    Eur J Neurosci; 2007 May; 25(9):2649-55. PubMed ID: 17466020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
    Brown DR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
    Masel J; Genoud N; Aguzzi A
    J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse.
    Kuczius T; Grassi J; Karch H; Groschup MH
    FEBS J; 2007 Mar; 274(6):1492-502. PubMed ID: 17302739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polysaccharide scaffold of PrP 27-30 is a common compound of natural prions and consists of alpha-linked polyglucose.
    Dumpitak C; Beekes M; Weinmann N; Metzger S; Winklhofer KF; Tatzelt J; Riesner D
    Biol Chem; 2005 Nov; 386(11):1149-55. PubMed ID: 16307480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.
    Arima K; Nishida N; Sakaguchi S; Shigematsu K; Atarashi R; Yamaguchi N; Yoshikawa D; Yoon J; Watanabe K; Kobayashi N; Mouillet-Richard S; Lehmann S; Katamine S
    J Virol; 2005 Jun; 79(11):7104-12. PubMed ID: 15890950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein-related proteins from zebrafish are complex glycosylated and contain a glycosylphosphatidylinositol anchor.
    Miesbauer M; Bamme T; Riemer C; Oidtmann B; Winklhofer KF; Baier M; Tatzelt J
    Biochem Biophys Res Commun; 2006 Mar; 341(1):218-24. PubMed ID: 16414019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hypothesis describing a potential link between molecular structure and TSE strains.
    Warwicker J
    Biochem Biophys Res Commun; 1997 Sep; 238(1):185-90. PubMed ID: 9299476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular prion proteins in human platelets show a phenotype different to those in brain tissues.
    Kuczius T; Kleinert J; Karch H; Sibrowski W; Kelsch R
    J Cell Biochem; 2011 Mar; 112(3):954-62. PubMed ID: 21328470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.